Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...

Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.

The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Researchers from the Japanese National Cerebral and Cardiovascular Center have found that the 5-year survival rates of patients with chronic thromboembolic pulmonary hypertension at their center ...

When Lauren Chapple of Shavertown crossed the finish line in a New Year’s Eve 5K, she was delighted, and even a little ...

Farhan Akhtar said, “Saddened to learn that the director of the OG Don is no more. RIP Chandra Barot-ji. Deepest condolences ...

Pulmonary Hypertension associated with Interstitial Lung Disease Market Insight, Epidemiology And Market Forecast - 2034The pulmonary hypert ...

Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

Pulmonary arterial hypertension (PAH) is a rare, progressive disorder impacting small pulmonary arteries, leading to increased vascular resistance and heart failure. The latest report forecasts ...

The pulmonary arterial hypertension (PAH) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, UK ...